Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
Here, Khurana et al. report the results of a phase 4 clinical trial with three FDA approved influenza vaccines and show that repeat influenza vaccination results in reduced antibody affinity maturation to hemagglutinin domain 1 irrespective of vaccine platform.
Guardado en:
Autores principales: | Surender Khurana, Megan Hahn, Elizabeth M. Coyle, Lisa R. King, Tsai-Lien Lin, John Treanor, Andrea Sant, Hana Golding |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25c5be5b8b3340e9bfab6fabc559795c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus
por: Gregory M. Frank, et al.
Publicado: (2015) -
Epitope-targeting platform for broadly protective influenza vaccines.
por: David F Zeigler, et al.
Publicado: (2021) -
Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains
por: Ewan P. Plant, et al.
Publicado: (2017) -
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial
por: Nadine G. Rouphael, et al.
Publicado: (2021) -
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Daniel Stadlbauer, et al.
Publicado: (2017)